Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis
Biomedicines
As revised 23 March 2023
https://www.mdpi.com/2227-9059/11/4/1087
Jenny - US: LDN, CRPS and Small Fibre Neuropathy (LDN; low dose naltrexone)
Off-label pharmacological treatment for neuropathic pain: A Delphi study by the Spanish Pain Society Neuropathic Pain Task Force
Pain Pract
29 October 2022
https://pubmed.ncbi.nlm.nih.gov/36308490/
Natasha - Australia: Chronic Pain and Cancer (LDN; low dose naltrexone)
‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever
Pain News Network
15 November 2022
https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever
Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions
Medical Dialogues
15 November 2022
https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374
The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details